Arkolith/Insider Trading/ANGN/Form 4/A

Ganzi Victor F

DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4/A · filed May 27, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.9M
Net Open-Market Flow
-$3.9M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2021Option exercise(X)614K$6.43$4.0M1.1M
Feb 9, 2021Sell(S)247K$16.00$3.9M823K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2021Option exercise(X)614K—$00

Transaction Codes

X
Exercise of in-the-money derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001601485-22-000044) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML